As of 2025-07-15, the Relative Valuation of XBiotech Inc (XBIT) is (18.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.89 USD, the upside of XBiotech Inc based on Relative Valuation is -723.9%.
The range of the Relative Valuation is (13.65) - (24.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 19.0x | 13.7x |
| Forward P/E multiples | 10.6x - 21.6x | 14.2x |
| Fair Price | (13.65) - (24.53) | (18.03) |
| Upside | -572.3% - -948.8% | -723.9% |
| Date | P/E |
| 2025-07-14 | -2.24 |
| 2025-07-11 | -2.19 |
| 2025-07-10 | -2.29 |
| 2025-07-09 | -2.37 |
| 2025-07-08 | -2.34 |
| 2025-07-07 | -2.36 |
| 2025-07-03 | -2.46 |
| 2025-07-02 | -2.49 |
| 2025-07-01 | -2.45 |
| 2025-06-30 | -2.30 |
| 2025-06-27 | -2.17 |
| 2025-06-26 | -2.22 |
| 2025-06-25 | -2.06 |
| 2025-06-24 | -2.07 |
| 2025-06-23 | -2.00 |
| 2025-06-20 | -1.93 |
| 2025-06-18 | -2.01 |
| 2025-06-17 | -2.02 |
| 2025-06-16 | -2.12 |
| 2025-06-13 | -2.04 |
| 2025-06-12 | -2.14 |
| 2025-06-11 | -2.17 |
| 2025-06-10 | -2.25 |
| 2025-06-09 | -2.27 |
| 2025-06-06 | -2.24 |
| 2025-06-05 | -2.21 |
| 2025-06-04 | -2.27 |
| 2025-06-03 | -2.24 |
| 2025-06-02 | -2.21 |
| 2025-05-30 | -2.21 |
| 2025-05-29 | -2.21 |
| 2025-05-28 | -2.25 |
| 2025-05-27 | -2.29 |
| 2025-05-23 | -2.20 |
| 2025-05-22 | -2.20 |
| 2025-05-21 | -2.22 |
| 2025-05-20 | -2.30 |
| 2025-05-19 | -2.38 |
| 2025-05-16 | -2.35 |
| 2025-05-15 | -2.31 |
| 2025-05-14 | -2.23 |
| 2025-05-13 | -2.31 |
| 2025-05-12 | -2.25 |
| 2025-05-09 | -2.14 |
| 2025-05-08 | -2.21 |
| 2025-05-07 | -2.16 |
| 2025-05-06 | -2.15 |
| 2025-05-05 | -2.21 |
| 2025-05-02 | -2.26 |
| 2025-05-01 | -2.27 |